Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SNP-ACTH (1-39) Gel / Cerium Pharma
NCT05696613: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy	Recruiting	3	148	Canada, US, RoW	SNP-ACTH (1-39) Gel, Rituximab, Rituxan or other biosimilars	Cerium Pharmaceuticals, Inc.	Primary Membranous Nephropathy	03/25	03/26